Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559). uri icon

authors

  • Hotchkiss, Richard S
  • Mayr, Florian B
  • Park, Pauline K
  • Ye, June
  • Catlett, Ian M
  • Girgis, Ihab G
  • Grasela, Dennis M
  • Colston, Elizabeth
  • Yende, Sachin
  • Angus, Derek C
  • Moldawer, Lyle L
  • Crouser, Elliott D
  • Martin, Greg S
  • Coopersmith, Craig M
  • Scott Brakenridge, MD

publication date

  • January 2019